New 52 Week High Today

Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 2:23 PM EDT

168.57

+4.56 (+2.78%)

Volume

3,723,774

52 week range

62.55 - 170.47

Open163.68
Day High170.47
Day Low162.00
Prev Close164.01
52 Week High170.47
52 Week High Date05/24/24
52 Week Low62.55
52 Week Low Date11/02/23

Key Stats

Market Cap64.603B
Shares Out383.24M
10 Day Average Volume4.95M
Dividend-
Dividend Yield-
Beta1.59
YTD % Change69.52

KEY STATS

Open163.68
Day High170.47
Day Low162.00
Prev Close164.01
52 Week High170.47
52 Week High Date05/24/24
52 Week Low62.55
52 Week Low Date11/02/23
Market Cap64.603B
Shares Out383.24M
10 Day Average Volume4.95M
Dividend-
Dividend Yield-
Beta1.59
YTD % Change69.52

RATIOS/PROFITABILITY

EPS (TTM)-15.66
P/E (TTM)-10.77
Fwd P/E (NTM)-21.78
EBITDA (TTM)-4.559B
ROE (TTM)-37.68%
Revenue (TTM)5.153B
Gross Margin (TTM)22.43%
Net Margin (TTM)-115.82%
Debt To Equity (MRQ)4.49%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Moderna Inc

Moderna and this solar name are among the most overbought stocks2 Hours AgoCNBC.com
Here's how U.S. government is responding to bird flu after second human case3 Hours AgoCNBC.com
The stock market gets nailed by the Fed, again. Plus, Starbucks' quiet comebackMay 22, 2024CNBC.com
Stocks making biggest moves midday: Target, Urban Outfitters, Tesla, ShopifyMay 22, 2024CNBC.com
Lightning Round: Hertz is too cheap right now, says Jim CramerMay 14, 2024CNBC.com

Content From Our Affiliates

QQQ ETF Update, 5/24/2024  8 Hours AgoTipRanks
SPY ETF Update, 5/23/2024  May 23, 2024TipRanks
Moderna and Pfizer in talks with U.S. on HSN1 bird flu vaccine, Reuters saysMay 22, 2024TipRanks
QQQ ETF Update, 5/22/2024May 22, 2024TipRanks
Moderna wins European patent case in Pfizer, BioNTech dispute, FT reportsMay 17, 2024TipRanks

Profile

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the...

Noubar Afeyan Ph.D.

Non-Executive Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

Jerh Collins

Chief Technical Operations and Quality Officer

James Mock

Chief Financial Officer

Brad Miller

Chief Information Officer

Address

325 BINNEY STREET

Cambridge, MA

02142

United States

https://www.modernatx.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ILMN Illumina Inc	106.13	+0.28	+0.26%
BIIB Biogen Inc	217.50	-0.56	-0.26%
BNTX Biontech SE	95.64	-3.36	-3.39%
GMAB Genmab A/S	28.10	-1.24	-4.23%
CRL Charles River Laboratories International Inc	217.05	-0.50	-0.23%